Mike Kratky
Stock Analyst at Leerink Partners
(4.34)
# 1,313
Out of 5,053 analysts
281
Total ratings
45.9%
Success rate
12.9%
Average return
Main Sectors:
Stocks Rated by Mike Kratky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AXGN Axogen | Reiterated: Buy | $22 → $52 | $36.17 | +43.77% | 18 | Oct 12, 2026 | |
| BSX Boston Scientific | Rated: Buy | $60 → $55 | $43.31 | +26.99% | 10 | Oct 12, 2026 | |
| ISRG Intuitive Surgical | Rated: Buy | $454 → $473 | $422.06 | +12.07% | 24 | Oct 12, 2026 | |
| PODD Insulet | Rated: Hold | $145 → $143 | $138.13 | +3.53% | 17 | Oct 12, 2026 | |
| PRCT PROCEPT BioRobotics | Rated: Hold | $29 → $20 | $19.10 | +4.71% | 20 | Oct 12, 2026 | |
| SYK Stryker | Rated: Buy | $410 → $353 | $282.55 | +24.93% | 2 | Oct 12, 2026 | |
| ZBH Zimmer Biomet Holdings | Rated: Hold | $101 → $97 | $92.08 | +5.34% | 2 | Oct 12, 2026 | |
| EW Edwards Lifesciences | Reiterated: Buy | $101 | $85.27 | +18.45% | 33 | Sep 28, 2026 | |
| BBNX Beta Bionics | Reiterated: Buy | $28 → $27 | $17.69 | +52.63% | 6 | Sep 17, 2026 | |
| MDT Medtronic | Reiterated: Buy | n/a | $93.01 | - | 8 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $327 → $374 | $320.01 | +16.87% | 8 | Jan 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $136 | $102.61 | +32.54% | 4 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $54.22 | n/a | 1 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $101 → $84 | $85.06 | n/a | 21 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $96 | $68.86 | n/a | 28 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $29 | $16.65 | n/a | 17 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $48 | $40.30 | n/a | 18 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $18 | $12.68 | n/a | 16 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $248.61 | n/a | 1 | Apr 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $71 | $0.71 | n/a | 4 | Jan 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1,166.51 | n/a | 1 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 → $46 | $0.968 | n/a | 11 | Sep 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $31 | $106.68 | n/a | 10 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $18.22 | n/a | 1 | Aug 15, 2022 |
Axogen
Oct 12, 2026
Reiterated: Buy
Price Target: $22 → $52
Current: $36.17
Upside: +43.77%
Boston Scientific
Oct 12, 2026
Rated: Buy
Price Target: $60 → $55
Current: $43.31
Upside: +26.99%
Intuitive Surgical
Oct 12, 2026
Rated: Buy
Price Target: $454 → $473
Current: $422.06
Upside: +12.07%
Insulet
Oct 12, 2026
Rated: Hold
Price Target: $145 → $143
Current: $138.13
Upside: +3.53%
PROCEPT BioRobotics
Oct 12, 2026
Rated: Hold
Price Target: $29 → $20
Current: $19.10
Upside: +4.71%
Stryker
Oct 12, 2026
Rated: Buy
Price Target: $410 → $353
Current: $282.55
Upside: +24.93%
Zimmer Biomet Holdings
Oct 12, 2026
Rated: Hold
Price Target: $101 → $97
Current: $92.08
Upside: +5.34%
Edwards Lifesciences
Sep 28, 2026
Reiterated: Buy
Price Target: $101
Current: $85.27
Upside: +18.45%
Beta Bionics
Sep 17, 2026
Reiterated: Buy
Price Target: $28 → $27
Current: $17.69
Upside: +52.63%
Medtronic
Jul 10, 2026
Reiterated: Buy
Price Target: n/a
Current: $93.01
Upside: -
Jan 15, 2026
Downgraded: Hold
Price Target: $327 → $374
Current: $320.01
Upside: +16.87%
Oct 16, 2025
Reiterated: Hold
Price Target: $136
Current: $102.61
Upside: +32.54%
Oct 14, 2025
Reiterated: Buy
Price Target: n/a
Current: $54.22
Upside: n/a
Oct 14, 2025
Reiterated: Buy
Price Target: $101 → $84
Current: $85.06
Upside: n/a
Oct 14, 2025
Reiterated: Hold
Price Target: $96
Current: $68.86
Upside: n/a
Oct 14, 2025
Reiterated: Buy
Price Target: $32 → $29
Current: $16.65
Upside: n/a
Oct 14, 2025
Reiterated: Buy
Price Target: $50 → $48
Current: $40.30
Upside: n/a
Aug 13, 2025
Reiterated: Buy
Price Target: $17 → $18
Current: $12.68
Upside: n/a
Apr 5, 2024
Reiterated: Buy
Price Target: n/a
Current: $248.61
Upside: n/a
Jan 11, 2024
Downgraded: Hold
Price Target: $71
Current: $0.71
Upside: n/a
Oct 16, 2023
Reiterated: Buy
Price Target: n/a
Current: $1,166.51
Upside: n/a
Sep 26, 2023
Reiterated: Buy
Price Target: $45 → $46
Current: $0.968
Upside: n/a
May 4, 2023
Reiterated: Hold
Price Target: $31
Current: $106.68
Upside: n/a
Aug 15, 2022
Reiterated: Buy
Price Target: $40
Current: $18.22
Upside: n/a